Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Silo Pharma, Inc. Acquires Software Assets from Larry King

PUBLIC · SILOOct 14, 2026

Acquiring Company

Silo Pharma

Acquired Company

Larry King

SarasotaPiedmontCommerce and ShoppingHealthcareInformation TechnologySoftwareIT Management

Description

On October 13, 2026, Silo Pharma, Inc. entered into an asset purchase agreement with Larry King to acquire certain software and related intellectual property. In exchange, Silo Pharma issued 150,000 shares of its common stock to the seller. The shares are subject to a lock-up period of twelve months following the effective date of the agreement.

Company Information

Company

Silo Pharma

Location

677 N. WASHINGTON BOULEVARD

Sarasota, Florida, United States

About

Silo Pharma. Inc. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the healthcare industry. For more information visit www.silopharma.com

Fundz sees it the moment Silo Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Daniel
Senior decision-maker at this company
••••••••@••••••••

See Daniel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Silo Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired Larry King?

Larry King was acquired by Silo Pharma, based in Sarasota. The deal was reported on October 14, 2026. Silo Pharma. Inc. Silo Pharma is publicly traded (SILO) and operates in Commerce and Shopping.

When did Silo Pharma acquire Larry King?

Silo Pharma's acquisition of Larry King was reported on October 14, 2026. On October 13, 2026, Silo Pharma, Inc. entered into an asset purchase agreement with Larry King to acquire certain software and related intellectual property. In exchange, Silo Pharma issued 150,000 shares of its common stock to the seller. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Larry King do?

Larry King is an independent software developer known for specialized software solutions. The company has developed unique intellectual properties that cater to specific market needs. It is privately held, operating in Information Technology, and is based in Piedmont.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.